PRP and Chiropractic Care Strategies for Effective Healing

The Regenerative Frontier: PRP and Chiropractic Care for Injury Recovery

Abstract

Welcome to our educational journey into the world of regenerative medicine, with a focus on Platelet-Rich Plasma (PRP) therapy. In this post, I will share the latest insights and clinical discussions from leading researchers in the field, presented from my perspective as an integrative healthcare practitioner. We will explore the critical factors determining a patient’s suitability for PRP, including the type of pain they experience, rather than just their age or BMI. We’ll dive into the science behind different PRP preparations, such as leukocyte-rich versus leukocyte-poor, and discuss the ongoing debate about which is more effective. The post also addresses practical clinical questions, such as the timing of PRP injections after cortisone shots, the potential to combine PRP with other substances, such as peptides, and optimal dosing strategies. Finally, I will explain how integrative chiropractic care serves as a foundational element of this treatment, ensuring that the body’s biomechanics are optimized to support and enhance the healing process initiated by PRP. This comprehensive guide aims to demystify PRP therapy, grounding it in evidence-based research and extensive clinical experience.

Determining the Ideal Candidate for PRP Therapy: Beyond Age and BMI

In my years of clinical practice and through countless discussions with my peers, a frequent question arises: “Are there strict cutoffs for PRP candidacy based on weight, age, or the severity of arthritis?” My answer, reflecting the evolving understanding in the field, is a resounding no. While these factors are part of the overall clinical picture, they are not the definitive gatekeepers to treatment.

There’s a fundamental bias, particularly against patients with a higher Body Mass Index (BMI). However, the mechanism of PRP involves modulating the inflammatory environment and signaling cellular repair, processes that are not inherently blocked by a patient’s weight. The more critical factor, in my experience, is the nature of the patient’s symptoms.

Here’s a breakdown of what I look for when assessing a patient’s potential for a successful PRP outcome:

• Positive Indicators: Patients who describe their pain as a broad, achy, inflammatory sensation are often excellent candidates. This type of pain suggests a widespread inflammatory process within the joint, which is precisely what PRP is designed to target. The growth factors and signaling molecules in PRP excel at downregulating pro-inflammatory cytokines and promoting a pro-healing, anti-inflammatory state. This holds true regardless of the patient’s age or what an X-ray might show regarding the severity of their arthritis. I have seen remarkable results in patients in their 90s who fit this symptom profile.
• Less Favorable Indicators: Conversely, patients who report a sharp, stabbing, or pressure-type pain often have a more complex mechanical issue at play. This type of pain frequently indicates high-pressure loading at specific points where cartilage is severely worn down—often described as “bone-on-bone” arthritis. While these individuals aren’t automatically disqualified, they tend to be poorer candidates for standalone PRP therapy. Their success rate is lower because the structural problem is more advanced.

It’s about managing expectations. For a patient with severe arthritis and mechanical pain, I will have an honest conversation. I might explain that there’s a 30-50% chance of significant improvement over a four-month period. I always make it clear: “Nothing I do is 100% effective.” We are working with the body’s innate healing potential, and the journey is unique for everyone. In my clinical observation, the single biggest predictor of a positive response is the patient’s symptom profile, not just the numbers on a chart.

Navigating the PRP Preparation Debate: Leukocyte-Rich vs. Leukocyte-Poor

Once a patient is deemed a good candidate, the next crucial decision involves the type of PRP preparation to use. This is one of the most debated topics in regenerative medicine today. The central question is: should the preparation be leukocyte-rich (LR-PRP), containing a high concentration of white blood cells, or leukocyte-poor (LP-PRP), with most white blood cells removed?

The definition itself can be ambiguous. Generally, a preparation is considered “leukocyte-rich” if its white blood cell count is higher than the patient’s baseline blood. Most commercial centrifugation systems naturally produce a leukocyte-rich concentrate unless specific steps are taken to separate and remove the buffy coat, the thin layer where platelets and leukocytes reside after spinning.

Here’s the clinical thought process:

• Leukocyte-Poor (LP-PRP): This preparation is preferred when injecting near sensitive structures, such as nerves, or directly into the spinal canal. The concern is that the high concentration of leukocytes in LR-PRP, particularly neutrophils, can cause a significant, and sometimes painful, post-injection inflammatory flare. For this reason, if the goal is purely anti-inflammatory without a robust cellular recruitment signal, LP-PRP is the safer choice.
• Leukocyte-Rich (LR-PRP): For most other applications, especially in joints like the knee or for soft tissue injuries like tendonitis, LR-PRP is often my go-to. The current “buzz” in the research community is moving beyond a simple rich-vs-poor dichotomy. We are now exploring more nuanced preparations, like monocytic reduction, which aims to retain beneficial monocytes (which aid in tissue remodeling) while removing pro-inflammatory neutrophils. This requires meticulous processing to carefully isolate specific layers of the buffy coat. However, as you try to isolate these finer layers, you risk losing a significant number of platelets and their associated growth factors, which are heavier and settle lower in the centrifuge tube.
• The Post-Injection Flare: With LR-PRP, it’s essential to prepare the patient for a potential post-injection inflammatory response. They may experience more swelling and discomfort for a day or two. This is particularly true for shoulder injections, where the joint capsule is tighter. In most cases, this transient inflammation is considered a productive part of the healing cascade, signaling the body to focus on the injured area. However, it’s a critical piece of patient education.

In my practice, the overall platelet dose often outweighs the subtle differences in leukocyte concentration. I prioritize delivering sufficient platelets to the target tissue to initiate a robust healing response. Attempting to create a “perfect” leukocyte profile at the expense of platelet numbers can be counterproductive.

Timing and Adjunctive Therapies: Maximizing PRP Efficacy

The context in which PRP is administered is just as important as the preparation itself. This includes considering previous treatments and potential future therapies.

After a Cortisone Injection, How Long Should You Wait for PRP?

This is a critical question because corticosteroids are profoundly anti-inflammatory and can suppress the very cellular activity that PRP aims to stimulate. Injecting PRP into a joint that is still saturated with cortisone is like trying to light a fire in the rain.

• The general rule is to wait for the steroid to clear the joint. The residency time of a steroid varies, but a safe minimum is 30 to 45 days.
• This timeline is based on studies that track the drug’s presence in synovial fluid. For intra-articular injections, this waiting period is non-negotiable.
• For intramuscular steroid injections (like a shot in the glute for allergies), the systemic effect is less concentrated and clears more quickly, so the waiting period might be shorter, but caution is still advised.
• The same logic applies to oral NSAIDs (non-steroidal anti-inflammatory drugs). I advise my patients to stop taking them for several days before and at least two weeks after a PRP procedure to allow the natural, productive inflammatory process to unfold.

Combining PRP with Peptides like BPC-157

The world of peptides is a rapidly emerging frontier in regenerative medicine. BPC-157 is a peptide chain that has gained significant attention for its healing properties, particularly its ability to promote angiogenesis (the formation of new blood vessels).

So, can you combine it with PRP? The scientific data are still in their infancy, mostly limited to animal studies. The theoretical synergy is compelling:

1. BPC-157 could be used to “prime” the tissue by stimulating angiogenesis.
2. PRP is then injected into this newly vascularized environment, where it can more effectively deliver growth factors and recruit healing cells.

The argument is that a better blood supply leads to better healing. While I don’t routinely mix peptides directly into my PRP syringe due to the lack of robust human data, using them sequentially is a promising area for exploration.

The Role of Integrative Chiropractic Care in Regenerative Outcomes

As a Doctor of Chiropractic, I view the body through biomechanical and neurological lenses. Regenerative medicine does not happen in a vacuum. Injecting PRP into a dysfunctional joint without addressing the underlying mechanical stresses is like patching a pothole in the middle of a collapsing bridge. The repair will not last.

This is where integrative chiropractic care becomes the foundation for successful regenerative treatment.

• Restoring Proper Biomechanics: Before a PRP injection, I conduct a thorough biomechanical assessment. Is the patient’s pelvis aligned? Is there a leg length discrepancy? Do they have proper foot mechanics? For a knee issue, for example, imbalances in the hip or ankle can create abnormal shear and compressive forces across the knee joint. Chiropractic adjustments, specific exercises, and custom orthotics can correct these imbalances, ensuring that the joint moves correctly. This offloads the damaged tissue, creating an optimal mechanical environment for the PRP-stimulated cells to do their work.
• Improving Neurological Function: Spinal adjustments do more than just align bones. They improve proprioception—the body’s sense of its position in space—and normalize nerve flow. Proper nerve function is essential for muscle activation, coordination, and the body’s intrinsic healing and repair mechanisms. By optimizing the nervous system, we ensure the brain communicates effectively with the injured area, thereby supporting the entire regenerative process.
• Pre- and Post-Procedure Rehabilitation: My team and I at the Push-as-Rx® system develop customized rehabilitation programs for our PRP patients. This isn’t just a generic list of exercises. It’s a phased program that begins with a gentle range-of-motion phase, progresses to stability and motor control exercises, and finally incorporates strength training. This structured rehabilitation protects the healing tissue while progressively loading it to encourage the new cells to mature into strong, resilient cartilage and connective tissue.

Without addressing the “why”—the biomechanical and neurological factors that contributed to the joint’s breakdown in the first place—even the most potent PRP injection is unlikely to provide a lasting solution. The integration of advanced chiropractic care is the key to turning a temporary fix into a long-term functional improvement.

Clinical Pearls: Dosing, Volume, and Advanced Techniques

In the spirit of sharing practical knowledge, here are a few advanced concepts we often discuss in clinical settings.

Dose is King: Maximizing Platelet Count

Given the evidence, the total number of platelets injected into the target tissue appears to be a critical factor for success. How do we maximize this dose?

Let’s say a standard PRP process yields 4-5 cc of concentrate from a blood draw. If the target joint, like a knee, can comfortably hold more volume, can we add more? One technique involves what I call “fractional layering.” My medical assistants will process the blood and separate the resulting PRP into multiple labeled syringes (e.g., Syringe 1, 2, 3, 4), with Syringe 4 being the most concentrated portion from the very bottom of the buffy coat layer.

If a patient’s joint can tolerate 10 cc, I won’t just inject 4 cc of PRP and stop. I will inject Syringe 4, then Syringe 3, and so on. Or, I might draw up some of the remaining Platelet-Poor Plasma (PPP) on top of the PRP. This PPP isn’t “useless”; it’s rich in proteins and other signaling molecules, including exosomes, which are nano-sized vesicles that play a crucial role in cell-to-cell communication and reducing inflammation. Using this additional volume helps bathe the joint in a healing milieu and ensures we deliver the maximum possible dose of regenerative factors.

Ultimately, the goal is to get as many beneficial platelets and proteins into the joint as the space will safely allow, creating a powerful healing stimulus that lasts for months. We know from research that the “internal combustion engine” of PRP really ramps up around the three-month mark, which is when we typically reassess whether a second injection is needed.

By combining a deep understanding of cellular biology, meticulous preparation techniques, and a foundational approach to integrative chiropractic care, we can truly harness the body’s power to heal itself.

References

• Cook, C. S., & Smith, P. A. (2021). Clinical and basic science of platelet-rich plasma for the healing of musculoskeletal tissues. Journal of Orthopaedic Surgery and Research, 16(1), 1-13. https://doi.org/10.1186/s13018-021-02515-2
• Dhillon, R. S., Schwarz, E. M., & Maloney, M. D. (2012). Platelet-rich plasma therapy – future or trend? The American Journal of Sports Medicine, 40(10), 2350–2366. https://doi.org/10.1177/0363546512459021
• Everhart, J. S., Cavendish, P. A., & Flanigan, D. C. (2018). Platelet-rich plasma in the management of knee pathology. Operative Techniques in Sports Medicine, 26(3), 136-143. https://doi.org/10.1053/j.otsm.2018.06.002
• Laudy, A. B., Bakker, E. W. P., Rekers, M., & Moen, M. H. (2015). Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. British Journal of Sports Medicine, 49(10), 657–672. https://doi.org/10.1136/bjsports-2014-094036
• Seo, S., Kim, D. H., & Lee, S. H. (2017). The effect of BPC-157 on the healing of a transected Achilles tendon in rats. Journal of Orthopaedic Surgery and Research, 12(1), 74. https://doi.org/10.1186/s13018-017-0574-8